Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Unique Technology is a pioneering Chinese enterprise focused on the integration of 3D printing technology with life sciences and clinical medicine. Established in 2011, the company has developed a robust portfolio of 3D bioprinting systems, most notably the Anyprint series, which facilitates the fabrication of biocompatible scaffolds and living tissues. Their research and development efforts are primarily directed toward regenerative medicine, including applications in skin grafting, bone repair, and personalized dental prosthetics. By providing both the hardware and the specialized bio-inks required for tissue engineering, Qingdao Unique supports researchers and clinicians in developing next-generation regenerative therapies. The company maintains a strong presence in the domestic Chinese market while actively pursuing international collaborations in the field of additive manufacturing for healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Unique.